ArticlePurinergic signalling2018
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.
Tali Fishman Jacob et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it